Willingdon Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
– Sell
-99,380
Closed -$2.1M – 121
2017
Q1
$2.1M Buy
99,380
+2,984
+3% +$58.2K 0.85% 50
2016
Q4
$1.44M Buy
+96,396
New +$1.71M 0.68% 63

Other funds holding DXCM

Willingdon Wealth Management's DXCM Position: Q2 2017 in Review

Willingdon Wealth Management sold out of DexCom (DXCM) in Q2 2017, closing a stake of 99,380 shares — an estimated $2.1M sold.

Willingdon Wealth Management first reported a position in DXCM in Q4 2016 and held it in 2 quarters. The position peaked at $2.1M in Q1 2017. 311 funds tracked by Wall St. Rank hold DXCM as of Q2 2017.

  • Willingdon Wealth Management reported no remaining DexCom position as of Q2 2017 after selling out during the quarter.
  • Willingdon Wealth Management sold 99,380 DexCom shares in Q2 2017, an estimated $2.1M.
  • Willingdon Wealth Management first reported a position in DexCom in Q4 2016 and held it in 2 quarters.
  • Willingdon Wealth Management's DexCom position peaked at $2.1M in Q1 2017.
  • 311 funds tracked by Wall St. Rank held DexCom as of Q2 2017.

Based on Willingdon Wealth Management's 13F filing for Q2 2017, filed 8 Aug 2017.